| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 5th, 2005 | 27 | No |
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.00 | 7.44 | -12.33 | 2 | 4 | 0 | 58 | 372.553 | 2 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| MP | 253 | TCI |
| Therapy | anti-androgen, alpha-reductase inhibitor | SMDC Pharmakon |
| PUBCHEM_PATENT_ID | EP0271220A1; EP0271220B1; EP0285382A2; EP0285382B1; EP0285383A2; EP0285383B1; EP0298652A2; EP0298652B1; EP0428366B1; EP0473226B1; EP0536843A1; EP0542802A1; EP0542802B1; EP0547691B1; EP0557301A1; EP0557301B1; EP0599376A2; EP0599376B1; EP0655458A2; EP065545 | IBM Patent Data |
